A feature News and Perspectives story on technological advances in oncology was published in Journal of Medical Internet Research. Authored by JMIR Correspondent Benedette Cuffari, “AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy” reports on the integration of deep learning and generative AI in radiopharmaceutical medicine, its impact on accelerating drug design, and how personalized dosimetry can improve patient outcomes.
How AI accelerates radiopharmaceutical drug discovery, optimizes personalized dosimetry
Important: this content is for informational purposes only and is not medical advice, a prescribing instruction, or a recommendation to act. Consult a licensed healthcare professional before taking any medication.
